Abemaciclib Slows Progression of Advanced Liposarcoma
In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold. Medscape Medical News source https://www.medscape.com/viewarticle/abemaciclib-slows-progression-advanced-liposarcoma-2026a1000i2g?src=rss